A startup can win a grant, rent a laboratory and fill a slide deck with promising charts. Then comes the less photogenic problem: getting somebody to buy. At Russia’s Skolkovo Foundation, that moment is becoming an increasingly explicit part of the pitch. A September 2026 partnership with Gazprombank puts a prospective customer inside the accelerator itself. The bank has problems to solve; the startups have technologies to test. Somewhere between the two, a business might happen.
The arrangement offers a useful way into an institution usually described through its buildings or its geopolitical ambitions. Skolkovo manages an innovation center, supports technology businesses and helps connect them with research, financing and industry. It is a nonprofit within the VEB.RF group. Venture capital is part of the machinery, alongside grant funding, business services and physical infrastructure. The Foundation’s practical product is help getting from an invention to a sale.
01A city was the opening bid
Skolkovo began in 2010 as a state project associated with then-President Dmitry Medvedev’s effort to diversify Russia’s economy. Businessman Viktor Vekselberg became its founding president. The early ambition stretched well beyond a collection of office leases: assemble entrepreneurs, researchers, investors and corporations in a setting designed to make new technologies commercially useful. Its original priorities included computing, biomedicine, energy efficiency, nuclear technology and space. The founding vision imagined an entrepreneurial culture growing around that concentration of talent and support.
International connections were central to the design. In 2011, MIT began helping develop the Skolkovo Institute of Science and Technology, or Skoltech, as a graduate research university. The university, the Foundation and the innovation center are related institutions with different jobs. The distinction matters: an academic collaboration is not a venture investment, and a university’s research output is not the Foundation’s revenue. Skolkovo’s ambitious map contained several organizations, each with its own responsibilities.
The bill was on the scale of a development program. In August 2013, a government plan envisaged 502 billion rubles in spending on the Skolkovo project during 2013-2020. Of that, 135.6 billion rubles was to come from the federal budget; private investors were expected to contribute the rest. Those were planned commitments, not an audited account of money ultimately spent. They show what was being attempted: a large, publicly backed investment in the conditions around entrepreneurship.
02The paperwork arrived early
Trouble over stewardship surfaced while the project was still young. In March 2013, the Foundation publicly answered investigators’ allegations concerning the handling of its funds. It defended depositing money at Metcombank, arguing that the arrangement protected liquidity and earned interest for Foundation activities. Its published response was a defense, not a finding that settled the allegations. Still, the episode exposed an early fault line: confidence in the institution handling public money could become a problem before its promised innovation economy had matured.
That history gives the familiar startup language a different weight. Experimentation tolerates failure; public finance demands accountability. A state-backed center has to accommodate both. The tension also appears at a smaller scale in today’s grants. The microgrant service requires agreements and reports on spending and results. For a founder, the funding comes with administrative work that belongs in the project schedule. A grant can buy an experiment; it cannot make the experiment succeed.
03The international bridge breaks
The decisive rupture in Skolkovo’s international academic story came after Russia’s full-scale invasion of Ukraine. MIT informed Skoltech in February 2022 that it was terminating their program. President L. Rafael Reif explained the decision in a letter that also praised the research and expressed sadness about ending the relationship. His explanation located the cause in the Russian government’s actions, rather than a failure by the scientists to produce worthwhile work.
“The program sprang from a particular historical moment.”
L. Rafael Reif, MIT president, February 2022
In August 2022, the United States designated the Foundation, Skoltech and Technopark Skolkovo under its Russia sanctions program. A further Treasury statement in January 2025 said Skolkovo had shifted in August 2024 toward projects connected with military development or increased military-industrial production. That is the U.S. government’s characterization and should be read with that attribution. It sits alongside the Foundation’s continuing public promotion of civilian applications in medicine, banking and construction.
For anyone studying the model, the implication is substantial. International research relationships require political conditions that a campus cannot manufacture. The people, laboratories and local companies can remain while a crucial external partnership disappears. Skolkovo’s experience limits the idea that enough infrastructure can insulate a technology cluster from the state surrounding it. The same public power that helped assemble the project also ties its prospects to national policy.
04What a founder actually gets
The current service catalog is practical and unusually broad. It includes microgrants, product and sales programs, research-and-development services and help assessing small technology companies. “Sk Product” works on product hypotheses and value propositions; “Sk Sales” concentrates on business-to-business selling. The R&D marketplace gives companies a route to commission technical work. These offerings address different bottlenecks: technical capability, a convincing product and access to buyers. A startup may need all three, but rarely in the same order.
For eligible participants, the microgrant listing sets a ceiling of 1.5 million rubles per award and 4 million rubles per participant in a calendar year. Eligibility depends on participant type, previous revenue and other funding obligations. The program supports defined research or commercialization tasks, with reporting attached. That makes it useful for a bounded piece of work. It is a poor substitute for a company’s entire financing plan, especially when the work requires several rounds of testing.
- 01Define the taskA buyer’s problem
- 02Build the evidenceResearch and testing
- 03Run a pilotA real operating setting
- 04Win the orderA commercial decision
An editorial reading of the support model. Each step requires a separate decision; support does not guarantee a sale.
The customers on the other side are corporations and public-sector organizations looking for technology they can use. The Foundation helps identify developers and arrange programs around those demands. Its business model combines public development funding with an organization of services and infrastructure; the venture-investment operation is a distinct entity in that wider group. Treating every resident’s sales as Foundation turnover would scramble the economics. Resident companies sell their own products and retain their own commercial identities.
05Follow the buyer into the room
Consider real estate. In May 2026, Cian became Skolkovo’s first official PropTech partner. Their agreement covered new property services, artificial intelligence and research. There was already a relationship to build on: Cian’s SmartDeal project, which handles electronic real-estate documentation, had participated since 2023. Skolkovo reported that SmartDeal’s revenue rose 30 percent and profit doubled in its first participation year. The announcement identified those results as a reason to deepen the collaboration. They are company-reported outcomes, not proof that membership alone caused the growth.
Medicine offers a more tangible example. In June 2026, the Foundation highlighted Steplife’s B5 prosthetic knee module and described bringing rehabilitation developers together with prospective purchasers and supporting organizations. It reported that Steplife’s 2025 revenue had exceeded 800 million rubles. The useful distinction is between the parties: Steplife makes the product; Skolkovo describes its role as helping connect development with deployment. A prosthesis reaching a user is a different kind of result from an accelerator graduation photograph.
The September Gazprombank accelerator makes the commercial sequence explicit. Participation is free. Up to ten selected projects in each of its startup and science tracks can receive 1 million rubles for hypothesis testing and development. Later pilot funding can reach 10 million rubles, subject to demonstrated business effect and the bank’s decision. Applications close October 13, 2026. The conditions are the point: a place in a program and a funded pilot are separate outcomes.
06Read the revenue with the label attached
Skolkovo reported aggregate resident revenue of 787.5 billion rubles for 2025, against 704.3 billion for 2024. That is about 11.8 percent growth in nominal rubles. The figures describe the resident portfolio, rather than the Foundation’s own income or the return on government spending. They also do not isolate the effect of inflation, changes in membership or support programs. The scale is meaningful. So is the boundary around what it measures.
RUB billion, nominal. Foundation-reported resident revenue. Bars share a zero baseline. These are not Foundation sales.
The geography is wider than the Moscow campus. June 2026 agreements covered four Russian regions, with plans tailored to their industrial needs. In Samara, the Foundation reported 67 participating companies and more than 1,000 technology jobs. Its regional operator, Zhigulevskaya Dolina, had worked with Skolkovo since 2018. That regional network matters to the model: support and corporate connections can reach companies where they already operate, alongside the flagship site’s offices and laboratories.
07Copy the connection, price the dependency
A founder comparing support options should start with the obstacle. Russia’s Foundation for Assistance to Small Innovative Enterprises runs the Start program for early-stage innovative businesses. A corporate accelerator may fit a company seeking a particular industry buyer. Private venture capital supplies a different financing relationship again. Skolkovo’s distinction is the combination: research services, participant support, infrastructure and routes into corporate demand within one institutional network. The right comparison depends on which of those a business actually needs.
The copyable lesson is to organize support around a specific commercial hurdle. Name the buyer’s problem. Fund a test that can answer it. Decide what result would justify a pilot, then who can authorize a purchase. That is an interpretation of the programs, not a promise of their results. It travels more easily than the physical campus. It also requires buyers with budgets, developers able to deliver and institutions willing to make decisions when the test is over.
Where those conditions are missing, introductions can end in meetings and grants can end in reports. Where international exchange is essential, Skolkovo’s political exposure may outweigh the attractions of local support. The Foundation remains an unusually concrete attempt to build the surroundings of entrepreneurship. Its most revealing measure will always be what happens after the surroundings have done their work: a technology leaves the demonstration, enters somebody’s operations and earns another order.